81 results on '"Mann, Graham"'
Search Results
2. Supplementary Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
3. Supplementary Figure Legends from Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous Melanomas
4. Supplementary Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
5. Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
6. Supplementary Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
7. Data from Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous Melanomas
8. Supplementary Figures and Tables from Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous Melanomas
9. Supplementary Figures and Tables from Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous Melanomas
10. Supplementary Figure Legends from Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous Melanomas
11. Supplementary Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
12. Supplementary Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
13. Supplementary Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
14. Supplementary Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
15. Supplementary Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
16. Data from Melanoma Prognosis: A REMARK-Based Systematic Review and Bioinformatic Analysis of Immunohistochemical and Gene Microarray Studies
17. Supplementary Table 1 from A High-Throughput Panel for Identifying Clinically Relevant Mutation Profiles in Melanoma
18. Supplementary Table 2 from A High-Throughput Panel for Identifying Clinically Relevant Mutation Profiles in Melanoma
19. Supplementary Table 2 from A High-Throughput Panel for Identifying Clinically Relevant Mutation Profiles in Melanoma
20. Data from A High-Throughput Panel for Identifying Clinically Relevant Mutation Profiles in Melanoma
21. Supplement 1 from Melanoma Prognosis: A REMARK-Based Systematic Review and Bioinformatic Analysis of Immunohistochemical and Gene Microarray Studies
22. Data from Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma
23. Supplementary Table 3 from A High-Throughput Panel for Identifying Clinically Relevant Mutation Profiles in Melanoma
24. Supplementary Data from Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma
25. Supplement 3 from Melanoma Prognosis: A REMARK-Based Systematic Review and Bioinformatic Analysis of Immunohistochemical and Gene Microarray Studies
26. Supplementary Table 3 from A High-Throughput Panel for Identifying Clinically Relevant Mutation Profiles in Melanoma
27. Supplement 3 from Melanoma Prognosis: A REMARK-Based Systematic Review and Bioinformatic Analysis of Immunohistochemical and Gene Microarray Studies
28. Supplementary Table 4 from A High-Throughput Panel for Identifying Clinically Relevant Mutation Profiles in Melanoma
29. Supplement 5 from Melanoma Prognosis: A REMARK-Based Systematic Review and Bioinformatic Analysis of Immunohistochemical and Gene Microarray Studies
30. Supplement 2 from Melanoma Prognosis: A REMARK-Based Systematic Review and Bioinformatic Analysis of Immunohistochemical and Gene Microarray Studies
31. Supplement 4 from Melanoma Prognosis: A REMARK-Based Systematic Review and Bioinformatic Analysis of Immunohistochemical and Gene Microarray Studies
32. Supplement 2 from Melanoma Prognosis: A REMARK-Based Systematic Review and Bioinformatic Analysis of Immunohistochemical and Gene Microarray Studies
33. Supplement 1 from Melanoma Prognosis: A REMARK-Based Systematic Review and Bioinformatic Analysis of Immunohistochemical and Gene Microarray Studies
34. Supplement 4 from Melanoma Prognosis: A REMARK-Based Systematic Review and Bioinformatic Analysis of Immunohistochemical and Gene Microarray Studies
35. Supplementary Data from Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma
36. Supplementary Table 1 from A High-Throughput Panel for Identifying Clinically Relevant Mutation Profiles in Melanoma
37. Data from Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma
38. Supplement 5 from Melanoma Prognosis: A REMARK-Based Systematic Review and Bioinformatic Analysis of Immunohistochemical and Gene Microarray Studies
39. Data from A High-Throughput Panel for Identifying Clinically Relevant Mutation Profiles in Melanoma
40. Data from Accuracy of Self-Reported Nevus and Pigmentation Phenotype Compared with Clinical Assessment in a Population-Based Study of Young Australian Adults
41. Supplementary Figure Legend from BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage
42. Figure S5 from PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma
43. Supplementary materials (clean version) from A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public
44. Supplementary Figure S1 from Accuracy of Self-Reported Nevus and Pigmentation Phenotype Compared with Clinical Assessment in a Population-Based Study of Young Australian Adults
45. Supplementary Table 2 from BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage
46. Supplementary Data from Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K BRAF-Mutant Melanoma
47. Supplementary Table S1 from Accuracy of Self-Reported Nevus and Pigmentation Phenotype Compared with Clinical Assessment in a Population-Based Study of Young Australian Adults
48. Data from Accuracy of Self-Reported Nevus and Pigmentation Phenotype Compared with Clinical Assessment in a Population-Based Study of Young Australian Adults
49. Personalised risk booklet - an example from A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public
50. Supplementary materials (clean version) from A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.